Point72 Asset Management, L.P. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,919,754
-1.0%
1,237,773
+9.4%
0.04%
-2.8%
Q2 2023$12,043,190
+11131.2%
1,131,879
+11004.5%
0.04%
Q1 2023$107,230
-98.5%
10,193
-98.4%
0.00%
-100.0%
Q4 2020$7,063,000
+563.8%
620,139
+676.0%
0.03%
+466.7%
Q4 2019$1,064,000
+50.9%
79,913
+109.2%
0.01%
+100.0%
Q3 2018$705,000
-96.6%
38,200
-96.5%
0.00%
-96.4%
Q2 2018$20,747,000
+1968.5%
1,085,106
+1569.4%
0.08%
+1975.0%
Q1 2018$1,003,000
-93.7%
65,000
-92.3%
0.00%
-95.5%
Q2 2017$15,942,000
-42.6%
844,400
-48.1%
0.09%
-42.6%
Q1 2017$27,774,000
+523.0%
1,628,018
+458.4%
0.16%
+400.0%
Q4 2016$4,458,000
-70.6%
291,532
-69.4%
0.03%
-71.0%
Q3 2016$15,148,000
-0.7%
953,927
-18.3%
0.11%
+2.9%
Q2 2016$15,261,000
+18.2%
1,167,183
-1.1%
0.10%
+5.1%
Q1 2016$12,915,000
-27.5%
1,180,500
-23.2%
0.10%
-32.7%
Q4 2015$17,824,000
+6.1%
1,537,900
-4.6%
0.15%
+11.4%
Q3 2015$16,801,000
+1.1%
1,612,400
+17.0%
0.13%
+14.8%
Q2 2015$16,626,000
+38.6%
1,378,600
+83.8%
0.12%
+40.2%
Q1 2015$12,000,000
-47.8%
750,000
-50.0%
0.08%
-49.1%
Q4 2014$22,982,000
+37.3%
1,500,100
+16.1%
0.16%
+27.8%
Q3 2014$16,744,0001,292,5000.13%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders